Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Sell
733
-417
-36% -$214K ﹤0.01% 1655
2026
Q1
$499K Buy
1,150
+16
+1% +$7.05K 0.01% 1447
2025
Q4
$372K Sell
1,134
-163
-13% -$52.4K ﹤0.01% 1622
2025
Q3
$415K Sell
1,297
-328
-20% -$90.6K ﹤0.01% 1527
2025
Q2
$447K Sell
1,625
-43
-3% -$8.75K 0.01% 1485
2025
Q1
$307K Buy
1,668
+77
+5% +$17.8K ﹤0.01% 1615
2024
Q4
$313K Buy
1,591
+26
+2% +$5K ﹤0.01% 1575
2024
Q3
$326K Sell
1,565
-49
-3% -$10.5K ﹤0.01% 1580
2024
Q2
$379K Buy
+1,614
New +$320K ﹤0.01% 1451

Other funds holding NVMI

Atria Investments's NVMI Position: Q2 2026 in Review

Atria Investments reduced its Nova (NVMI) stake by 36% in Q2 2026, selling an estimated $214K and leaving 733 shares worth $398K. The position accounts for ﹤0.01% of the portfolio, ranked #1655.

Atria Investments first reported a position in NVMI in Q2 2024 and has held it in 9 quarters since. The position peaked at $499K in Q1 2026. 345 funds tracked by Wall St. Rank hold NVMI as of Q2 2026.

  • Atria Investments held 733 shares of Nova worth $398K as of Q2 2026.
  • Atria Investments sold 417 Nova shares in Q2 2026, an estimated $214K.
  • Nova made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1655 holding.
  • Atria Investments first reported a position in Nova in Q2 2024 and has held it in 9 quarters since.
  • Atria Investments's Nova position peaked at $499K in Q1 2026.
  • 345 funds tracked by Wall St. Rank held Nova as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.